£10,000 in savings? I’d aim for £633k in FTSE 100 shares and £25k a year of passive income

I’m aiming for a blistering second income by prioritising investment in FTSE 100 shares. Here’s how this strategy could supercharge my wealth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

For decades, investment strategies focused on FTSE 100 shares have proven to be a great way to generate long-term wealth. My own stock-buying philosophy is geared heavily towards Footsie shares, complemented with a peppering of FTSE 250 stocks.

Who can blame me? The UK’s leading share index has delivered a brilliant 7.5% average annual return since 1984. That’s much better than the return investors could have made with low-yielding savings accounts over that period.

Past performance is no guarantee of future gains. But let me show you how I could make a healthy passive income for retirement with FTSE 100 stocks.

A £25k+ passive income

On my journey to create long-term wealth I’ve laid down the following criteria:

  • To put £10,000 in a tax-efficient Stocks and Shares ISA at the beginning
  • To invest this sum — along with an extra £200 each month — in FTSE 100 shares
  • To reinvest any dividends I receive in more Footsie stocks
  • To retire in 30 years, giving my retirement fund plenty of time to grow

If I manage to meet all of these criteria — and assuming that the Footsie’s 7.5% average yearly return remains in tact — I would have made an impressive £633,194 by the end o it.

This investing strategy could make me almost £634k. Source: thecalculatorsite.com.
This investing strategy could make me more than £633k. Source: thecalculatorsite.com

If I then chose to withdraw 4% of this sum down each year I would enjoy a decent income of £25,327. Why 4%, you ask? At this level, I could draw a passive income for three decades before my retirement pot ran dry.

A FTSE 100 share I’d buy

I would also need to spread my net wide and not just invest in a small pool of similar Footsie stocks. This narrow focus could see me miss out on growth opportunities elsewhere, and leave me exposed to greater risk from industry- and economic-related factors.

Instead, I’d look to build a broad portfolio of at least 15 stocks that span different sectors, geographies, and which perform differently at each stage of the economic cycle. This way I can continue growing my portfolio when times are good as well as when things get tough.

I’d also seek companies that boast robust economic moats, as investing expert Warren Buffett would describe. These are competitive advantages that safeguard long-term earnings and defend market share from rival businesses. GSK (LSE:GSK) is a perfect example of one such stock, I feel.

Buffett once held the company’s shares through his Berkshire Hathaway firm, and it’s easy to see why. Many of its drugs (like its Shingrix shingles treatment) are leaders in their fields. The firm is also a leading force in the fast-growing vaccines market thanks to heavy investment in recent years.

It’s also not easy and cheap to develop pharmaceuticals products, which protects the firm from the threat of new market entrants. GSK spent a whopping £5.5bn on research and development in 2022. That’s more than the market-cap of many FTSE 100 companies.

Developing drugs is an expensive and complicated business. And troubles at the lab bench can have a significant impact on earnings. But GSK has an excellent track record on this front, which is why I’m looking to add it to my portfolio when I next have cash to invest.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing For Beginners

After getting promoted from the FTSE 250, what’s next for Hiscox?

Jon Smith mulls over the latest reshuffle in the FTSE 250 and explains why he feels this top stock could…

Read more »

Investing Articles

Want dividend yields up to 9.9%? Here’s 3 FTSE 100 and FTSE 250 shares to consider

Looking to turbocharge your passive income? These high dividend yield FTSE 100 and FTSE 250 stocks could be just what…

Read more »

Investing Articles

2 shares absolutely crushing the FTSE 100 in 2024!

Not all FTSE 100 stocks are sleepy and meandering. This duo has surged more than four times higher than the…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Growth Shares

The FTSE 100 could hit 9,000 points by year end. Here’s why

Jon Smith talks through some factors that could help to lift the FTSE 100 to a new all-time high and…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

I’d seriously consider buying this UK technology small-cap stock today

Today's positive trading figures and a runway of growth potential ahead make this small-cap stock look attractive to me now.

Read more »

Investing Articles

It’s October! Does this mean UK stocks are going to crash?

Whisper it quietly, but four of the five biggest one-day falls in the FTSE 100 have been in the month…

Read more »

Investing Articles

With new nuclear energy deals in view, Rolls-Royce’s share price looks cheap to me anywhere under £11.48

Rolls-Royce’s share price dipped after a problem on a Cathay Pacific flight but has now bounced back on positive news…

Read more »

Investing Articles

Is the Greggs share price now a screaming buy for me after falling 10% this month?

Harvey Jones watched the Greggs share price climb and climb, but decided it was too expensive for him. Should he…

Read more »